Lv1
20 积分 2024-11-12 加入
A random forest-based metabolic risk model to assess the prognosis and metabolism-related drug targets in ovarian cancer
1天前
已完结
Metabolic dependencies and targets in ovarian cancer
1天前
已完结
Developing a novel image marker to predict the clinical outcome of neoadjuvant chemotherapy (NACT) for ovarian cancer patients
3个月前
已完结
Pathologic response to neoadjuvant chemotherapy in ovarian cancer and its association with outcome: A surrogate marker of survival
3个月前
已完结
Predicting Neoadjuvant Chemotherapy Response and High-Grade Serous Ovarian Cancer From CT Images in Ovarian Cancer with Multitask Deep Learning: A Multicenter Study
3个月前
已完结
Reliability of IOTA score and ADNEX model in the screening of ovarian malignancy in postmenopausal women
3个月前
已完结
Combining a symptom index, CA125 and HE4 (triple screen) to detect ovarian cancer in women with a pelvic mass
3个月前
已完结
Targeting the immune checkpoint B7-H3 for next-generation cancer immunotherapy
4个月前
已完结
Immunotherapy for Ovarian Cancer: Disappointing or Promising?
4个月前
已完结
Immunotherapy for ovarian cancer: towards a tailored immunophenotype-based approach
4个月前
已完结
皖公网安备34019202002308
